Prostate cancer refers to the epithelial malignant tumor that occurs in the prostate. The incidence of prostate cancer in the tumor registration areas in 2012 is 99,200/100, 000, ranking the 6th in malignant tumor incidences in males, and the mortality rate is only after lung cancer. Early prostate cancer usually has no symptoms and can be easily dismissed.

     With the benefits of intuitive results, stability, simple operation, rich sample sources, etc., fluorescent in situ hybridization(FISH), through detection of special locus,  provides support in early diagnosis of prostate cancer and providing important basis for predicting prognosis for prostate cancer patients.

Product list    




Pack size


TMPRSS2 Break Apart FISH Probe Kit


10 Assay/Kit